Benchstrength Secures $62M Early-Stage Venture Capital Fund
Benchstrength, a New York City-based venture capital firm, has closed its first fund with investments from prominent institutions like...
Adaptive Clinical Trial Design Adaptive Trial Design Addiction Psychiatry AI in Clinical Trials alcohol use disorder Alzheimer's Disease Article Clinical Operations Clinical Research Clinical Trial Design Clinical Trial Operations Clinical Trial Ops Brief Clinical Trial Quality Clinical Trials CLINOPS WATCHDOG CNS Drug Development CNS Trials Conference Coverage Decentralized Clinical Trials Digital Health Technologies dual diagnosis eClinical Tech News eClinical Technology EMA Executive Interviews FDA Enforcement FDA Guidance FDA Real-World Evidence FDA Regulation FDA Regulatory Strategy GCP Compliance GLP-1 Receptor Agonists Ketamine Therapy Oncology Trials Opinion Parkinson's Disease Platform Trials Psilocybin MDMA Psychedelic Clinical Trials PSYCH PULSE Real-World Evidence site activation Site Operations study startup Treatment-Resistant Depression
Benchstrength, a New York City-based venture capital firm, has closed its first fund with investments from prominent institutions like...
CardioFocus, Inc. has initiated the VISION AF clinical trial, marking the first use of its investigational OptiShot™ Pulsed Field...
Scientists at City of Hope have identified a protein, YTHDF2, that helps blood cancer cells evade CAR T cell...
eClinical Solutions and Snowflake have partnered to integrate eClinical’s elluminate Clinical Data Cloud with the Snowflake AI Data Cloud....
Silexion Therapeutics is developing SIL-204, a next-generation siRNA therapy targeting a broad range of KRAS mutations prevalent in difficult-to-treat...
In this interview, we speak with Doug Cohen, CEO of IR Medtek, about their groundbreaking noninvasive cancer detection technology....
Fresenius Kabi has launched Epinephrine Injection, USP, the first generic version of epinephrine in a 1mg/1mL vial, in the...
The FDA has granted Breakthrough Therapy Designation to Gilead Sciences’ Trodelvy for treating extensive-stage small cell lung cancerlung cancer...
In the high-stakes world of pharmaceuticals, intellectual property (IP) rights are crucial for protecting innovation and ensuring returns on...
At SCOPE Summit Europe, Estrella García, PhD, an Executive Director at Almirall, shared her insights on navigating the complexities...